Literature DB >> 6280047

Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.

A F Stewart, M Adler, C M Byers, G V Segre, A E Broadus.   

Abstract

Prolonged immobilization may result in hypercalcemia, hypercalciuria, and osteoporosis. Although bone resorption is central to this syndrome, the mechanism of resorption is uncertain. In particular, the role of systemic calcium-regulating hormones remains unclear. In 14 immobilized subjects we measured fasting calcium excretion, 24-hour urinary calcium excretion during restricted calcium intake, the renal phosphorus threshold, plasma 1,25-dihydroxyvitamin D, nephrogenous cyclic AMP, and immunoreactive parathyroid hormone. Mean serum calcium levels were normal, but fasting and 24-hour calcium excretion were markedly elevated (0.28 mg per deciliter of glomerular filtrate and 314 mg per 24 hours, respectively). The mean levels of serum phosphorus (4.8 mg per deciliter) and the renal phosphorus threshold (4.3 mg per deciliter) were elevated. Mean plasma 1,25-dihydroxyvitamin D was strikingly reduced (9.9 pg per milliliter), as were nephrogenous cyclic (0.64 nmol per deciliter of glomerular filtrate) and immunoreactive parathyroid hormone in both assays. These findings indicate that the parathyroid--1,25-dihydroxyvitamin D axis is suppressed in patients with immobilization-induced hypercalciuria, as would be predicted by a model of resorptive hypercalciuria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280047     DOI: 10.1056/NEJM198205133061903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  53 in total

Review 1.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

Review 2.  Immobilization osteoporosis: a review.

Authors:  P Minaire
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

3.  Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.

Authors:  William A Bauman; Christopher M Cirnigliaro; Michael F La Fountaine; LeighAnn Martinez; Steven C Kirshblum; Ann M Spungen
Journal:  J Bone Miner Metab       Date:  2014-08-27       Impact factor: 2.626

4.  Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure.

Authors:  Michael P Whyte; Rattana Leelawattana; William R Reinus; Chang Yang; Steven Mumm; Deborah V Novack
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

Review 5.  Disorders involving calcium, phosphorus, and magnesium.

Authors:  Sharon M Moe
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

6.  Osteopenia in men with mild and severe ankylosing spondylitis.

Authors:  H J Baek; S W Kang; Y J Lee; K C Shin; E B Lee; C D Yoo; Y W Song
Journal:  Rheumatol Int       Date:  2004-10-05       Impact factor: 2.631

7.  Increased calcium absorption in prehypertensive spontaneously hypertensive rat. Role of serum 1,25-dihydroxyvitamin D3 levels and intestinal brush border membrane fluidity.

Authors:  K Lau; C B Langman; U Gafter; P K Dudeja; T A Brasitus
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden.

Authors:  Kirsten Kusumi; Brian Becknell; Andrew Schwaderer
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

9.  Acute suppression of bone turnover with calcium infusion in persons with spinal cord injury.

Authors:  William A Bauman; Run-Lin Zhang; Nancy Morrison; Ann M Spungen
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

10.  31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury.

Authors:  William A Bauman; Mark A Korsten; Miroslav Radulovic; Gregory J Schilero; Jill M Wecht; Ann M Spungen
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.